Invasive treatment of coronary artery disease in octogenarians

Ewa Gaszewska-Zurek1, Paweł Zurek, Joanna Ciosek

  • 1III Klinika Kardiologii Slaskiej Akademii Medycznej, ul. Ziołowa 47, 40-635 Katowice, Poland. pawewazurek@poczta.onet.pl

Kardiologia Polska
|December 20, 2005
PubMed

Insights

Invasive treatments for coronary artery disease in octogenarians are feasible and safe. Percutaneous coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) show acceptable risks and satisfactory outcomes in elderly patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) frequently affects patients over 80 years old.
  • The efficacy and safety of invasive treatments in this demographic remain a critical clinical question.

Purpose of the Study:

  • To compare one-year clinical outcomes of percutaneous coronary angioplasty (PTCA) versus coronary artery bypass grafting (CABG) in octogenarians.
  • To evaluate outcomes in octogenarians compared to a younger control group (60-65 years).

Main Methods:

  • Retrospective analysis of 63 patients over 80 undergoing PTCA or CABG for CAD.
  • Comparison with 40 younger patients (60-65 years) treated similarly.
  • Assessment of procedural risks, complications, and one-year clinical status.

Main Results:

  • In octogenarians, 39 PTCA and 24 CABG procedures were performed.
  • In-hospital mortality was 3%, with 18 periprocedural complications.
  • One-year follow-up revealed 6 deaths, with higher recurrent angina rates after PTCA than CABG.

Conclusions:

  • Invasive treatment for coronary artery disease in octogenarians is feasible.
  • Satisfactory clinical outcomes and acceptable procedural risks were observed in this elderly population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...